Biolinco

Biolinco develops an AI-enabled, high-throughput cell line screening platform for biopharmaceutical manufacturers to efficiently identify optimal cell lines using DNA barcoding technology, addressing the issue of low-yielding cell lines HQ: Baltimore, United States. Industry: ['Artificial intelligence and machine learning', 'Big Data', 'Healthtech', 'Manufacturing']. Techstars 2026. biolinco.com